Press releases

Swedish Orphan Biovitrum AB (publ) (Sobi™) is hosting a Capital Markets Day at Karolinska Institutet Biomedicum in Solna, Sweden, today. Presentations from senior management and an external expert are showcasing how Sobi is well positioned to use its rare strength to...

05/14/2019 - 12:45

Today, Sobi™ and Sanofi will present data demonstrating that Elocta® (efmoroctocog alfa) and Alprolix® (eftrenonacog alfa) can provide perioperative haemostatic control across a wide spectrum of major and minor surgeries in subjects of all ages with severe haemophilia A...

05/10/2019 - 09:05

The Sobi AGM was convened earlier today in Stockholm and voted in favour of the resolutions proposed at the meeting, including:

Adoption of the profit and loss statements and balance sheet and discharge of liability

The AGM adopted the income statements and the balance...

05/09/2019 - 17:30
Regulatory

Swedish Orphan Biovitrum AB (publ) (Sobi™) has appointed Amy Pott as the new Head of Sobi North America. She takes over effective today, replacing Rami Levin who is leaving Sobi.

“Sobi North America is entering a new phase in line with Sobi’s growth strategy, with the...

04/30/2019 - 13:00

Swedish Orphan Biovitrum AB (publ) (Sobi™) today announces its results for the first quarter 2019. Total revenues were SEK 3,265 M (1,964), with 66 per cent revenue growth in the quarter compared with Q1 2018 (54 per cent at constant exchange rates (CER)). EBITA1...

04/25/2019 - 08:00
Regulatory

Press contacts

Subscribe to our press releases and financial reports